Subhra Mandal

Loop profile ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Antiretroviral Therapy

Top Venues

Antimicrobial agents and chemotherapy

Nanomaterials (Basel, Switzerland)

Creighton University

Scuola Internazionale Superiore di Studi Avanzati (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Creighton University Jul 01 2018

United States

Research Assistant Professor :: Pharmacy Practice

Creighton University School of Pharmacy and Health Professions Feb 01 2015

United States

Post-Doctoral fellow :: School of Pharmacy and Health Professions

Universitair Medisch Centrum Sint Radboud Feb 01 2011 - Jan 01 2014

Netherlands

Post-Doctoral researcher :: Tumor Immunology

Education History

Scuola Internazionale Superiore di Studi Avanzati Nov 01 2007 - Oct 21 2010

Italy

PHD :: Statistical Biophysics

Publications

Subhra Mandal, Shawnalyn W Sunagawa, Pavan Kumar Prathipati, Michael Belshan, Annemarie Shibata, Christopher J Destache
Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study. Nanomaterials (Basel, Switzerland) 12 (11) (2022)
Subhra Mandal, Pavan Kumar Prathipati, Shawnalyn W Sunagawa, Christopher J Destache
A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure Prophylaxis. Antimicrobial agents and chemotherapy 65 (4) (2021)
Amit N Pandya, Pavan Kumar Prathipati, Pooja Hegde, Wei Li, Kyle F Graham, Subhra Mandal, Kristen M Drescher, Christopher J Destache, Diane Ordway, Mary Jackson, E Jeffrey North
Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection. Antimicrobial agents and chemotherapy 63 (3) (2019)